Loading clinical trials...
Loading clinical trials...
An Open-label Study to Assess the Bioavailability, Safety, Local Tolerance, and Efficacy of 0.5% Ivermectin Cream in Subjects 6 Months to 3 Years of Age With Pediculus Humanus Capitis (Head Lice) Infestation
Conditions
Interventions
0.5% Ivermectin Cream
Locations
5
United States
Children's Investigational Research Program
Bentonville, Arkansas, United States
Universal BioPharma Research, Inc
Dinuba, California, United States
Impact Clinical Trials
Los Angeles, California, United States
Lice Source Solutions Inc
Plantation, Florida, United States
Spence Medical Research L.L.C
Picayune, Mississippi, United States
Start Date
September 1, 2009
Primary Completion Date
November 1, 2009
Completion Date
November 1, 2009
Last Updated
April 25, 2012
NCT07191457
NCT04878276
NCT05378477
NCT00528021
NCT03236168
NCT00591331
Lead Sponsor
Topaz Pharmaceuticals Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions